Hormone Replacement Therapy Research Today is a free monthly online journal that collates and summarizes the latest research about Hormone Replacement Therapy, including details on hrt, menopause, natural hrt, effects, risks.

Volume 4 (2007), Issue 5 (May)

1. Local cytokine levels associated with delayed-type hypersensitivity responses: modulation by gender, ovariectomy, and estrogen replacement.
   J Endocrinol, 193(2): 291-7. [Abstract] [Full-text]
2. Options for hormone therapy in women who have had a hysterectomy.
   Menopause, 14(3): 592-7; quiz 598-9. [Abstract] [Full-text]
3. Surgical versus natural menopause: cognitive issues.
   Menopause, 14(3): 572-9. [Abstract] [Full-text]
4. Molecular analysis of human endometrium: short-term tibolone signaling differs significantly from estrogen and estrogen + progestagen signaling.
   J Mol Med, 85(5): 471-80. [Abstract] [Full-text]
5. The effects of short-term hormone replacement therapy on long-term bone mineral density.
   Climacteric, 10(3): 257-63. [Abstract] [Full-text]
6. Neutral effect of ultra-low-dose continuous combined estradiol and norethisterone acetate on mammographic breast density.
   Climacteric, 10(3): 249-56. [Abstract] [Full-text]
7. Number of women needed in a prospective trial to prove potential cardiovascular benefit of hormone replacement therapy.
   Climacteric, 10(3): 238-43. [Abstract] [Full-text]
8. Distinct lipid/lipoprotein profiles and hormonal responsiveness in nine ethnic groups of postmenopausal Asian women: the Pan-Asia Menopause (PAM) study.
   Climacteric, 10(3): 225-37. [Abstract] [Full-text]
9. Women's needs for CAM information to manage menopausal symptoms.
   Climacteric, 10(3): 215-24. [Abstract] [Full-text]
10. The role of local vaginal estrogen for treatment of vaginal atrophy in postmenopausal women: 2007 position statement of The North American Menopause Society.
    Menopause, 14(3): 355-69; quiz 370-1. [Abstract] [Full-text]
11. Decline in use of hormone therapy among postmenopausal women in the United Kingdom.
    Menopause, 14(3): 462-7. [Abstract] [Full-text]
12. Effect of ultra-low-dose transdermal estradiol on breast density in postmenopausal women.
    Menopause, 14(3): 391-6. [Abstract] [Full-text]
13. Levonorgestrel-releasing intrauterine system as an adjunct to estrogen for the treatment of menopausal symptoms--a review.
    Menopause, 14(3): 550-4. [Abstract] [Full-text]
14. Canadian Society for the Study of the Aging Male: response to health Canada's position paper on testosterone treatment.
    J Sex Med, 4(3): 558-66. [Abstract] [Full-text]
15. Changes of the prescription of hormone therapy in menopausal women: an observational study in Taiwan.
    BMC Public Health, 7: 56. [Abstract] [Full-text]
16. Ovarian cancer and hormone replacement therapy in the Million Women Study.
    Lancet, 369(9574): 1703-10. [Abstract] [Full-text]
17. Addition of medroxyprogesterone acetate to conjugated equine estrogens results in insulin resistance in adipose tissue.
    Metabolism, 56(6): 830-7. [Abstract] [Full-text]
18. Effects of castration and hormone replacement on male sexual behavior and pattern of expression in the brain of sex-steroid receptors in BALB/c AnN mice.
    Comp Biochem Physiol A Mol Integr Physiol, 147(3): 607-15. [Abstract] [Full-text]
19. Simultaneous estradiol and levonorgestrel transdermal delivery from a 7-day patch: in vitro and in vivo drug deliveries of three formulations.
    Drug Dev Ind Pharm, 33(4): 373-80. [Abstract] [Full-text]
20. Circulating chemoattractants RANTES, negatively related to endogenous androgens, and MCP-1 are differentially suppressed by hormone therapy and raloxifene.
    Atherosclerosis, 193(1): 142-50. [Abstract] [Full-text]
21. Colon cancer risk and different HRT formulations: a case-control study.
    BMC Cancer, 7: 76. [Abstract] [Full-text]
22. Hormone replacement therapy and breast cancer in former users of oral contraceptives--The Norwegian Women and Cancer study.
    Int J Cancer, 121(3): 645-8. [Abstract] [Full-text]

© 2004-2008 Hormone Replacement Therapy Research Today. All Rights Reserved.